These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 15510113)
1. Generic drugs allowed in global trial of AIDS therapy. Check E Nature; 2004 Oct; 431(7012):1028. PubMed ID: 15510113 [No Abstract] [Full Text] [Related]
2. Global AIDS trial denied patients as US balks at generic drug use. Check E Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219 [No Abstract] [Full Text] [Related]
4. US to limit AIDS trials in developing nations. Ready T Nat Med; 2003 Jun; 9(6):629. PubMed ID: 12778141 [No Abstract] [Full Text] [Related]
5. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
6. South Africa may keep door closed to generic AIDS drugs. Cherry M Nature; 2001 Apr; 410(6832):1013. PubMed ID: 11323627 [No Abstract] [Full Text] [Related]
7. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector. Podsakoff GM Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827 [No Abstract] [Full Text] [Related]
8. Several AIDS drugs tentatively approved. FDA Consum; 2005; 39(5):3. PubMed ID: 16421982 [No Abstract] [Full Text] [Related]
9. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
10. Production of low cost AIDS drugs to continue in Brazil. Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899 [No Abstract] [Full Text] [Related]
11. South African firm gets US approval for AIDS drugs. AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15846847 [No Abstract] [Full Text] [Related]
12. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges. Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289 [No Abstract] [Full Text] [Related]
13. 'Better adherence vital in AIDS therapies'. Macilwain C Nature; 1997 Nov; 390(6658):326. PubMed ID: 9389462 [No Abstract] [Full Text] [Related]
14. Controversy grows over parallel track for experimental AIDS drug. N Y State J Med; 1990 Mar; 90(3):169. PubMed ID: 2107475 [No Abstract] [Full Text] [Related]
15. ACTIS and ATIS: new resources for AIDS information, part two. Fitzpatrick RB Med Ref Serv Q; 2003; 22(1):31-8. PubMed ID: 12627689 [TBL] [Abstract][Full Text] [Related]
16. Brands in peril as Brazil strives to keep AIDS drugs free. Butler D Nature; 2004 Jun; 429(6991):493. PubMed ID: 15175719 [No Abstract] [Full Text] [Related]
17. NCI plans attack on HIV resistance. Science; 1997 May; 276(5313):667. PubMed ID: 9157541 [No Abstract] [Full Text] [Related]
18. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed. Venkatesh KK; Mayer KH; Carpenter CC Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332 [TBL] [Abstract][Full Text] [Related]
19. Two AIDS medicines back on WHO prequalification list. Wkly Epidemiol Rec; 2004 Dec; 79(50):449-50. PubMed ID: 15646322 [No Abstract] [Full Text] [Related]
20. AIDS researchers seek criteria for vaccines. Check E Nature; 2003 May; 423(6936):107. PubMed ID: 12736647 [No Abstract] [Full Text] [Related] [Next] [New Search]